"Cotton O'Neil Cancer Center consolidates the outpatient cancer services of Stormont Vail and Cotton O'Neil. The center features the latest technology, including one of the few Trilogy Image-Guided Radiotherapy linear accelerator systems in the state of Kansas."

During the past decade, Cotton O'Neil Cancer Center / Stormont Vail Health conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 81 clinical trials were completed, i.e. on average, 197.6% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 29 clinical trials were completed. i.e. 483.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cotton O'Neil Cancer Center / Stormont Vail Health" #1 sponsor was "SWOG Cancer Research Network" with 58 trials, followed by "National Cancer Institute (NCI)" with 52 trials sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cotton O'Neil Cancer Center / Stormont Vail Health" #1 collaborator was "National Cancer Institute (NCI)" with 101 trials as a collaborator, "Cancer and Leukemia Group B" with 13 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "NCIC Clinical Trials Group" with 12 trials as a collaborator and "SWOG Cancer Research Network" with 11 trials as a collaborator. Other collaborators include 35 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Cotton O'Neil Cancer Center / Stormont Vail Health" are "Breast Cancer" (19 trials), "Lymphoma" (14 trials), "Lung Cancer" (12 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Cotton O'Neil Cancer Center / Stormont Vail Health" in a lesser frequency.

Most popular intervention types in "Cotton O'Neil Cancer Center / Stormont Vail Health" are "Drug" (122 trials), "Other" (87 trials), "Biological" (64 trials), "Radiation" (28 trials) and "Procedure" (19 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (47 trials), "Quality-of-Life Assessment" (28 trials), "Paclitaxel" (13 trials), "Bevacizumab" (11 trials) and "Questionnaire Administration" (11 trials). Other intervention names were less common.

The vast majority of trials in "Cotton O'Neil Cancer Center / Stormont Vail Health" are 120 trials for "All" genders, 32 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Cotton O'Neil Cancer Center / Stormont Vail Health". undefined are not yet recruiting, 9 are recruiting, 62 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in Cotton O'Neil Cancer Center / Stormont Vail Health, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Cotton O'Neil Cancer Center / Stormont Vail Health, 3 "Phase 1" clinical trials were conducted, 48 "Phase 2" clinical trials and 101 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".